Work With Us
Three ways to collaborate with us. No matter what you choose, we are always fully committed to innovation, excellence, and impactful results.
Transforming Therapeutic Discovery with Tailored Partnerships
Too many therapies fail because current models cannot fully capture human disease. Our OrganoCore® Discovery Platform combines deep modeling with high throughput screening and AI data analysis to understand disease, discover novel targets, and select best possible therapeutic candidates. In partnerships, we stand shoulder to shoulder with industry leaders to deliver innovative and improved medicines to patients in need.
Recognizing that no two partners are the same, we offer tailored partnerships. Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.
Answer your research questions with Customized Fee-for-Service Solutions
MIMETAS offers tailored fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds using our OrganoCore® Discovery Platform. From early drug discovery, and compound validation to lead candidate selection and ADME-tox testing, our services offer targeted support across all phases. Our world class scientists, utilizing robust human disease models and assays, are dedicated to advancing your programs and addressing each research question.
Our flexible fee-for-service model allows you to scale your projects according to demand and timelines. With over 170 successful projects, we deliver insights that drive your research forward. As an extension of your team, MIMETAS provides the expertise and resources needed for effective R&D.
Ready-to-use Models for Your Laboratory
Our OrganoReady program is made for you when you need defined assays in ADME (absorption, distribution, metabolism, and excretion) and tox (toxicology). We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.
